Shield Therapeutics (STX)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

2.95p
   
  • Change Today:
      0.28p
  • 52 Week High: 7.65p
  • 52 Week Low: 1.23p
  • Currency: UK Pounds
  • Shares Issued: 782.06m
  • Volume: 40,674,235
  • Market Cap: £23.07m
  • Beta: 1.88

STX Overview

Shield is a de-risked commercial stage, pharmaceutical company focused on addressing iron deficiency in adults with or without anaemia. Our clear purpose is to develop products that help patients become people again, enabling them to enjoy the things that make a difference in their everyday lives.

Key Personnel

Independent Non-Executive Director: Fabiana Lacerca Allen
Independent Non-Executive Director: Peter Llewellyn-Davies
Interim CEO: Anders Lundstrom
Non-Executive Chairman: Hans-Peter Hasler
Non-Executive Dir: Christian Schweiger

Contact Details

Address: Northern Design Centre, Baltic Business Quarter, Gateshead Quays, United Kingdom, NE8 3DF
Phone: +44 (0) 191 511 8500
Website: http://www.shieldtherapeutics.com/

Listings

Sector: Pharma and Biotech(LSE)
Index: FTSE AIM All-Share
ISIN: GB00BYV81293

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

STX Market Data

Currency UK Pounds
Share Price 2.95p
Change Today 0.28p
% Change 10.28 %
52 Week High 7.65p
52 Week Low 1.23p
Volume 40,674,235
Shares Issued 782.06m
Market Cap £23.07m
Beta 1.88

STX Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
34.63% below the market average34.63% below the market average34.63% below the market average34.63% below the market average34.63% below the market average
76.00% above the sector average76.00% above the sector average76.00% above the sector average76.00% above the sector average76.00% above the sector average
Price Trend
30.96% below the market average30.96% below the market average30.96% below the market average30.96% below the market average30.96% below the market average
14.29% below the sector average14.29% below the sector average14.29% below the sector average14.29% below the sector average14.29% below the sector average
Income Not Available
Growth
64.44% above the market average64.44% above the market average64.44% above the market average64.44% above the market average64.44% above the market average
70.59% above the sector average70.59% above the sector average70.59% above the sector average70.59% above the sector average70.59% above the sector average

What The Brokers Say

Strong Buy 0
Buy 0
Neutral 1
Sell 0
Strong Sell 0
Total 1
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

STX Dividends

No dividends found

Trades for 21-Nov-2024

Time Volume / Share Price
16:30 50,000 @ 2.95p
16:25 500,000 @ 3.23p
16:24 250,000 @ 2.90p
16:17 33,878 @ 2.94p
16:16 15,000 @ 2.94p

Top of Page